EXR
31
-4
CFG
40
-6
ADM
34
-3
NKE
39
-3
PRU
48
-3
EQIX
62
-3
MCO
70
-3
NEM
72
11
AON
32
-4
AIZ
68
-5
GWW
58
-2
DIS
68
-4
K
41
-3
TRV
46
3
LUV
40
-5
EXC
61
-2
SRCL
37
-9
HBAN
51
-2
HCP
78
16
UA
29
-4
EXR
31
-4
CFG
40
-6
ADM
34
-3
NKE
39
-3
PRU
48
-3
EQIX
62
-3
MCO
70
-3
NEM
72
11
AON
32
-4
AIZ
68
-5
GWW
58
-2
DIS
68
-4
K
41
-3
TRV
46
3
LUV
40
-5
EXC
61
-2
SRCL
37
-9
HBAN
51
-2
HCP
78
16
UA
29
-4
Financhill
Back

Viking Therapeutics 10K Form

Buy
61

VKTX
Viking Therapeutics

Last Price:
74.28
Seasonality Move:
18.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-6.13M
Price / Cash Flow: 0
Annual Sales: $8.47
Price / Book: 8.13

Profitability

EPS (TTM): -0.93000
Net Income (TTM): $-93.72M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Viking Therapeutics Earnings Forecast

Key Viking Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Viking Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Buy
61
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics a Buy or a Sell?